Unternehmen Pacgen Life Science Corp Toronto S.E.
Aktien
PBS
CA69374M1041
PBS
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Christina Yip
CEO | Chief Executive Officer | - | 10.04.06 |
Frank Lin
FOU | Founder | - | - |
Chung Yue Wang
CEO | Chief Executive Officer | 80 | 23.04.04 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ming-Chih Hsuan
BRD | Director/Board Member | 70 | 01.09.10 |
Chung Yue Wang
CEO | Chief Executive Officer | 80 | 23.04.04 |
Christina Yip
CEO | Chief Executive Officer | - | 10.04.06 |
Tsung Ching Lin
BRD | Director/Board Member | - | 01.04.09 |
Frank Lin
FOU | Founder | - | - |
Meng Hui Lin
BRD | Director/Board Member | - | - |
Cherie Lin
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 64 815 969 | 29 754 556 ( 45,91 %) | 0 | 45,91 % |
Unternehmenskontakt
Pacgen Life Science Corp.
701 West Georgia Street Suite 1500
V7Y 1C6, Vancouver
+
http://www.pacgenlife.com/![Straße Pacgen Life Science Corp(PBS)](https://cdn.zonebourse.com/static/address/1411233.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+34.14% | 51.12 Mrd. | |
-6.54% | 39.4 Mrd. | |
+34.92% | 38.48 Mrd. | |
+12.62% | 26.36 Mrd. | |
-12.11% | 26.22 Mrd. | |
-13.43% | 20.96 Mrd. | |
+43.73% | 14.02 Mrd. | |
+31.81% | 12.49 Mrd. | |
-4.54% | 11.61 Mrd. |